Status: current, Defined. Date: 31-May 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 547081000036115 | doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL injection, 10 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 547091000036118 | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | Is a | doxorubicin hydrochloride (as pegylated liposomal) | true | Inferred relationship | Some | ||
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | has intended active ingredient | doxorubicin hydrochloride (as pegylated liposomal) | true | Inferred relationship | Some | 1582563262 | |
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | has Australian BoSS | doxorubicin hydrochloride (as pegylated liposomal) | true | Inferred relationship | Some | 1582563262 | |
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1582563263 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Liposomal Doxorubicin (Sun) 20 mg/10 mL injection, 10 mL vial | Is a | True | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | Inferred relationship | Some | |
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial | has MPUU | True | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | Inferred relationship | Some | 1 |
| Caelyx 20 mg/10 mL injection, 10 mL vial | Is a | True | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | Inferred relationship | Some | |
| Lipodox 20 mg/10 mL injection, 10 mL vial | Is a | True | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | Inferred relationship | Some | |
| doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 x 10 mL vials | has MPUU | True | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR